Back to top

Image: Bigstock

Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%

Read MoreHide Full Article

Ovid Therapeutics Inc. (OVID - Free Report) was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.83 to $7.40 in the past one-month time frame.

The company has seen one negative estimate revision in the past two months, while its Zacks Consensus Estimate for the current quarter has also moved lower in the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Ovid Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical – Biomedical and Genetics industry is Gamida Cell Ltd. (GMDA - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


OVID THERAPEUTC (OVID) - free report >>

Gamida Cell Ltd. (GMDA) - free report >>

Published in